MicroRNA Expression Signature in Human Calcific Aortic Valve Disease

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2017 May 13

PMID 28497051

Citations 17

Authors

Hui Wang

Jing Shi

Beibei Li

Qiulian Zhou

Xiangqing Kong

Yihua Bei

Affiliations

Soon will be listed here.

Abstract

Altered microRNA (miRNA, miR) expression has been related to many disease processes; however, the miRNA expression signature in calcific aortic valve disease (CAVD) is unclear. In this study, microarrays were used to determine the miRNA expression signature of tissue samples from healthy individuals ( = 4) and patients with CAVD ( = 4). TargetScan, PITA, and microRNAorg 3-way databases were used to predict the potential target genes. DIANA-miRPath was used to incorporate the aberrant miRNAs into gene pathways. miRNA microarrays identified 92 differentially expressed miRNAs in CAVD tissues. The principal component analysis (PCA) of these samples and the unsupervised hierarchical clustering analysis based on the 92 aberrantly expressed miRNAs noted that miRNA expression could be categorized into two well-defined clusters that corresponded to healthy control and CAVD. Bioinformatic analysis showed the miRNA targets and potential molecular pathways. Collectively, our study reported the miRNA expression signature in CAVD and may provide potential therapeutic targets for CAVD.

Citing Articles

Molecular Features of Calcific Aortic Stenosis in Female and Male Patients.

Le Nezet E, Marqueze-Pouey C, Guisle I, Clavel M CJC Open. 2024; 6(9):1125-1137.

PMID: 39525825 PMC: 11544188. DOI: 10.1016/j.cjco.2024.06.002.

Expression of miR-223 to predict outcomes after transcatheter aortic valve implantation.

Eyileten C, Skrobucha A, Starczynski M, Boszko M, Jarosz-Popek J, Fitas A Cardiol J. 2022; 31(1):111-123.

PMID: 36200549 PMC: 10919566. DOI: 10.5603/CJ.a2022.0090.

The Effect of Osteoprotectin (OPG)/Receptor Activator of Nuclear Factor-B Ligand (RANKL)/Receptor Activator of Nuclear Factor-B (RANK) Gene Methylation on Aortic Valve Calcified.

Luo W, Song Y, Wang J, Yang X, Li Z, Cong H Biomed Res Int. 2022; 2022:1592576.

PMID: 35993046 PMC: 9391187. DOI: 10.1155/2022/1592576.

Identification of Key Non-coding RNAs and Transcription Factors in Calcific Aortic Valve Disease.

Guo S, Zhang E, Zhang B, Liu Q, Meng Z, Li Z Front Cardiovasc Med. 2022; 9:826744.

PMID: 35845040 PMC: 9276990. DOI: 10.3389/fcvm.2022.826744.

Clinical Significance of miR-21-5p in Predicting Occurrence and Progression of Uremic Vascular Calcification in Patients with End-Stage Renal Disease.

Wu R, Zhou S, Liu M, An H, Wang Z, Liu T Yonsei Med J. 2022; 63(3):252-258.

PMID: 35184427 PMC: 8860934. DOI: 10.3349/ymj.2022.63.3.252.

References

Melman Y, Shah R, Das S . MicroRNAs in heart failure: is the picture becoming less miRky?. Circ Heart Fail. 2014; 7(1):203-14. DOI: 10.1161/CIRCHEARTFAILURE.113.000266. View

Xu J, Tang Y, Bei Y, Ding S, Che L, Yao J . miR-19b attenuates H2O2-induced apoptosis in rat H9C2 cardiomyocytes via targeting PTEN. Oncotarget. 2016; 7(10):10870-8. PMC: 4905445. DOI: 10.18632/oncotarget.7678. View

Creemers E, Tijsen A, Pinto Y . Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?. Circ Res. 2012; 110(3):483-95. DOI: 10.1161/CIRCRESAHA.111.247452. View

Wang H, Bei Y, Shen S, Huang P, Shi J, Zhang J . miR-21-3p controls sepsis-associated cardiac dysfunction via regulating SORBS2. J Mol Cell Cardiol. 2016; 94:43-53. DOI: 10.1016/j.yjmcc.2016.03.014. View

Yan T, Liu Y, Cui K, Hu B, Wang F, Zou L . MicroRNA-126 regulates EPCs function: implications for a role of miR-126 in preeclampsia. J Cell Biochem. 2013; 114(9):2148-59. DOI: 10.1002/jcb.24563. View

Tao L, Bei Y, Chen P, Lei Z, Fu S, Zhang H . Crucial Role of miR-433 in Regulating Cardiac Fibrosis. Theranostics. 2016; 6(12):2068-2083. PMC: 5039681. DOI: 10.7150/thno.15007. View

Shi J, Liu H, Wang H, Kong X . MicroRNA Expression Signature in Degenerative Aortic Stenosis. Biomed Res Int. 2016; 2016:4682172. PMC: 4989063. DOI: 10.1155/2016/4682172. View

Latsios G, Tousoulis D, Androulakis E, Papageorgiou N, Synetos A, Tsioufis C . Monitoring calcific aortic valve disease: the role of biomarkers. Curr Med Chem. 2012; 19(16):2548-54. DOI: 10.2174/092986712800492940. View

Iung B, Vahanian A . Epidemiology of acquired valvular heart disease. Can J Cardiol. 2014; 30(9):962-70. DOI: 10.1016/j.cjca.2014.03.022. View

10.

Galeone A, Brunetti G, Oranger A, Greco G, Di Benedetto A, Mori G . Aortic valvular interstitial cells apoptosis and calcification are mediated by TNF-related apoptosis-inducing ligand. Int J Cardiol. 2013; 169(4):296-304. DOI: 10.1016/j.ijcard.2013.09.012. View

11.

Lv D, Liu J, Zhao C, Sun Q, Zhou Q, Xu J . Targeting microRNAs in Pathological Hypertrophy and Cardiac Failure. Mini Rev Med Chem. 2015; 15(6):475-8. DOI: 10.2174/1389557515666150324124751. View

12.

Freeman R, Otto C . Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation. 2005; 111(24):3316-26. DOI: 10.1161/CIRCULATIONAHA.104.486738. View

13.

Roy S, Khanna S, Hussain S, Biswas S, Azad A, Rink C . MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc Res. 2009; 82(1):21-9. PMC: 2652741. DOI: 10.1093/cvr/cvp015. View

14.

Lei Z, Sluijter J, van Mil A . MicroRNA Therapeutics for Cardiac Regeneration. Mini Rev Med Chem. 2015; 15(6):441-51. DOI: 10.2174/1389557515666150324123913. View

15.

Condorelli G, Latronico M, Cavarretta E . microRNAs in cardiovascular diseases: current knowledge and the road ahead. J Am Coll Cardiol. 2014; 63(21):2177-87. DOI: 10.1016/j.jacc.2014.01.050. View

16.

Piccoli M, Bar C, Thum T . Non-coding RNAs as modulators of the cardiac fibroblast phenotype. J Mol Cell Cardiol. 2016; 92:75-81. DOI: 10.1016/j.yjmcc.2015.12.023. View

17.

Liu X, Xiao J, Zhu H, Wei X, Platt C, Damilano F . miR-222 is necessary for exercise-induced cardiac growth and protects against pathological cardiac remodeling. Cell Metab. 2015; 21(4):584-95. PMC: 4393846. DOI: 10.1016/j.cmet.2015.02.014. View

18.

Bergler-Klein J, Gyongyosi M, Maurer G . The role of biomarkers in valvular heart disease: focus on natriuretic peptides. Can J Cardiol. 2014; 30(9):1027-34. DOI: 10.1016/j.cjca.2014.07.014. View

19.

Vlachos I, Kostoulas N, Vergoulis T, Georgakilas G, Reczko M, Maragkakis M . DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways. Nucleic Acids Res. 2012; 40(Web Server issue):W498-504. PMC: 3394305. DOI: 10.1093/nar/gks494. View

20.

Wang H, Bei Y, Shi J, Xiao J, Kong X . Non-Coding RNAs in Cardiac Aging. Cell Physiol Biochem. 2015; 36(5):1679-87. DOI: 10.1159/000430141. View